Chemical Business Newsbase articles from November 2006

Chemical Business Newsbase archives from November 2006

Rhodia 2005: Income statement.
November 30, 2006... (From Chemical Business NewsBase - Company Reports - CBNB) For its fiscal 2005, Rhodia SA has reported net sales of EUR 5085 M (EUR 4693 M for its fiscal 2004), recurring EBITDA of EUR 595 M (EUR 525 M), of which: polyamide EUR 249 M (EUR...

Schering 2005: Key data.
November 30, 2006... (From Chemical Business NewsBase - Company Reports - CBNB) For its fiscal 2005, Schering AG has reported net sales of EUR 5308 M (EUR 4907 M for its fiscal 2004), R&D expenditure of EUR 982 M (EUR 918 M), operating profit of EUR 928 M...

Schering 2005: Top selling products.
November 30, 2006... (From Chemical Business NewsBase - Company Reports - CBNB) For its fiscal 2005 Schering AG's ten best selling products had total sales of EUR 3048 M (+12% on its fiscal 2004), of which: Betaferon EUR 867 M (+11%), Yasmin EUR 586 M (+36%),...

Schering 2005: Net sales by business area and important indication areas. [1 table in original article].
November 30, 2006... (From Chemical Business NewsBase - Company Reports - CBNB) For its fiscal 2005, Schering AG has reported net sales of EUR 5308 M (EUR 4907 M for its fiscal 2004). A large table gives a breakdown of product sales by business segment:...

Schering 2005: Overview of the last five years. [1 table in original article].
November 30, 2006... (From Chemical Business NewsBase - Company Reports - CBNB) For its fiscal 2005, Schering AG has reported net sales of EUR 5308 M (EUR 4907 M for its fiscal 2004), R&D expenditure of EUR 982 M (EUR 918 M), operating profit of EUR 928 M...

Schering 2005: Key market launches and development projects.
November 30, 2006... (From Chemical Business NewsBase - Company Reports - CBNB) For its fiscal 2005, Schering AG has reported on its key market launches and development projects. Angeliq (drospirenone; launch in the US in 2006, peak sales forecast of EUR 150...

Schering 2005: Female contraception.
November 30, 2006... (From Chemical Business NewsBase - Company Reports - CBNB) For its fiscal 2005, Schering AG has reported on its Female Contraception segment. Sales were EUR 1681 M (EUR 1473 M for its fiscal 2004) and were 32% of total sales (30%). Women...

Schering 2005: Menopause management.
November 30, 2006... (From Chemical Business NewsBase - Company Reports - CBNB) For its fiscal 2005, Schering AG has reported on its Menopause Management segment. Sales were EUR 169 M (EUR 167 M for its fiscal 2004) and were 3% of total sales (3%). Menopause...

Schering 2005: Andrology.
November 30, 2006... (From Chemical Business NewsBase - Company Reports - CBNB) For its fiscal 2005, Schering AG has reported on its Andology segment. No financial information was presented. The company's andrology activities are focused on two main areas:...

Schering 2005: Diagnostic imaging highlights.
November 30, 2006... (From Chemical Business NewsBase - Company Reports - CBNB) For its fiscal 2005, Schering AG has reported on its Diagnostic Imaging segment. Sales were EUR 1404 M (EUR 1308 M for its fiscal 2004) and were 27% of total sales (27%). The...

Schering 2005: Magnetic resonance imaging.
November 30, 2006... (From Chemical Business NewsBase - Company Reports - CBNB) For its fiscal 2005, Schering AG has reported on its Magnetic Resonance Imaging segment. Sales of MRI contrast agents were EUR 362 M (EUR 332 M for its fiscal 2004) and were 7% of...

Schering 2005: X-Ray contrast media.
November 30, 2006... (From Chemical Business NewsBase - Company Reports - CBNB) For its fiscal 2005, Schering AG has reported on its X-Ray Contrast Media segment. Sales were EUR 583 M (EUR 574 M for its fiscal 2004) and were 11% of total sales (12%). X-ray...

Schering 2005: Application technologies for contrast agents.
November 30, 2006... (From Chemical Business NewsBase - Company Reports - CBNB) For its fiscal 2005, Schering AG has reported on its Application Technologies for Contrast Agents segment. Sales were EUR 329 M (EUR 271 M for its fiscal 2004) and were 6% of...

Schering 2005: Radiopharmaceuticals.
November 30, 2006... (From Chemical Business NewsBase - Company Reports - CBNB) For its fiscal 2005, Schering AG has reported on its Radiopharmaceuticals segment. Sales were EUR 125 M (EUR 125 M for its fiscal 2004) and were 2% of total sales (2%)....

Schering 2005: Net sales by region.
November 30, 2006... (From Chemical Business NewsBase - Company Reports - CBNB) For its fiscal 2005, Schering AG has reported net sales of EUR 5308 M (EUR 4907 M for its fiscal 2004), of which: Europe EUR 2456 M (EUR 2349 M), the US EUR 1391 M (EUR 1225 M),...

Schering 2005: Specialised therapeutics highlights.
November 30, 2006... (From Chemical Business NewsBase - Company Reports - CBNB) For its fiscal 2005, Schering AG has reported on its Specialised Therapeutics segment. Sales were EUR 1179 M (EUR 1126 M for its fiscal 2004), of which: CNS drugs EUR 936 M (EUR...

Schering 2005: Gynaecology & andrology highlights.
November 30, 2006... (From Chemical Business NewsBase - Company Reports - CBNB) For its fiscal 2005, Schering AG has reported on its Gynaecology & Andrology segment. Sales were EUR 1979 M (EUR 1766 M for its fiscal 2004) and were 37% of total sales (36%)....

Schering 2005: Oncology highlights.
November 30, 2006... (From Chemical Business NewsBase - Company Reports - CBNB) For its fiscal 2005, Schering AG has reported on its Oncology segment. Sales were EUR 429 M (EUR 420 M for its fiscal 2004) and were 8% of total sales (9%). Highlights: Leadership...

Schering 2005: Solid tumours.
November 30, 2006... (From Chemical Business NewsBase - Company Reports - CBNB) For its fiscal 2005, Schering AG has reported on its Solid Tumours segment. Sales were EUR 184 M (EUR 185 M for its fiscal 2004) and were 3% of total sales (4%). Solid Tumours:...

Schering 2005: R&D Gynaecology & andrology.
November 30, 2006... (From Chemical Business NewsBase - Company Reports - CBNB) For its fiscal 2005, Schering AG has reported on its R&D Gynaecology & Andrology. In Gynecology, the company continues to set the highest quality standards for future products...

Schering 2005: Research & development.
November 30, 2006... (From Chemical Business NewsBase - Company Reports - CBNB) For its fiscal 2005, Schering AG has reported on its R&D program. The company's global expenses on research and development increased by 7% to EUR 982 M in 2005. This equaled 19%...

Schering 2005: Haematological oncology.
November 30, 2006... (From Chemical Business NewsBase - Company Reports - CBNB) For its fiscal 2005, Schering AG has reported on its Haematological Oncology segment. Sales were EUR 245 M (EUR 235 M for its fiscal 2004) and were 5% of total sales (5%)....

Schering 2005: R&D Specialized therapeutics.
November 30, 2006... (From Chemical Business NewsBase - Company Reports - CBNB) For its fiscal 2005, Schering AG has reported on its R&D Specialized Therapeutics. In order to fully exploit the underlying potential in the Specialized Therapeutics business...

Schering 2005: R&D Diagnostic imaging.
November 30, 2006... (From Chemical Business NewsBase - Company Reports - CBNB) For its fiscal 2005, Schering AG has reported on its R&D Diagnostic Imaging. The company's current research and development projects are directed towards disease-specific and...

Schering 2005: Europe region.
November 30, 2006... (From Chemical Business NewsBase - Company Reports - CBNB) For its fiscal 2005, Schering AG has reported on its Europe region. Europe region: The geographic segment referred to in this annual report as the Europe Region comprises the...

Schering 2005: US region.
November 30, 2006... (From Chemical Business NewsBase - Company Reports - CBNB) For its fiscal 2005, Schering AG has reported on its US region. The geographic region referred to in this annual report as the US Region comprises the US and Puerto Rico. The...

Schering 2005: Latin America/Canada region.
November 30, 2006... (From Chemical Business NewsBase - Company Reports - CBNB) For its fiscal 2005, Schering AG has reported on its Latin America/Canada region. The geographic segment referred to in this annual report as the Latin America/Canada Region...

Schering 2005: Asia Pacific region.
November 30, 2006... (From Chemical Business NewsBase - Company Reports - CBNB) For its fiscal 2005, Schering AG has reported on its Asia Pacific region. The geographic segment referred to in this annual report as the Asia/Pacific Region comprises the...

Schering 2005: Other activities.
November 30, 2006... (From Chemical Business NewsBase - Company Reports - CBNB) For its fiscal 2005, Schering AG has reported on its Other activities. Other Activities comprise those activities that are not sufficiently significant to qualify as individual...

Schering 2005: R&D Oncology.
November 30, 2006... (From Chemical Business NewsBase - Company Reports - CBNB) For its fiscal 2005, Schering AG has reported on its R&D Oncology. As a result of many years of work by its top researchers, the company maintains a prominent leadership position...

Schering 2005: Selected development projects. [1 table in original article].
November 30, 2006... (From Chemical Business NewsBase - Company Reports - CBNB) For its fiscal 2005, Schering AG has reported on selected development projects. Data are tabulated as: project/indication, description, and status, and categorised as: gynaecology...

Schering 2005: Recent acquisitions and divestitures.
November 30, 2006... (From Chemical Business NewsBase - Company Reports - CBNB) For its fiscal 2005, Schering AG has reported on its recent acquisitions and divestitures. In Jan 2005, the company announced the signing of a license agreement with Novartis...

Schering 2005: Japan region.
November 30, 2006... (From Chemical Business NewsBase - Company Reports - CBNB) For its fiscal 2005, Schering AG has reported on its Japan region. The geographic segment referred to in this annual report as the Japan Region covers the geographical territory...

Schering 2005: Personnel.
November 30, 2006... (From Chemical Business NewsBase - Company Reports - CBNB) For its fiscal 2005, Schering AG has reported on its personnel. Changes in personnel structure: The Schering AG Group employed 24,658 people worldwide as of 31 Dec 2005, which is...

Schering 2005: Patent expiration dates. [1 table in original article].
November 30, 2006... (From Chemical Business NewsBase - Company Reports - CBNB) A large table sets forth the patent expiration dates of certain of Schering AG's top selling products in its major markets. Data are tabulated as: product, France, Germany, Italy,...

Schering 2005: Capital expenditures.
November 30, 2006... (From Chemical Business NewsBase - Company Reports - CBNB) For its fiscal 2005, Schering AG has reported on its capital expenditures. The company generally fund capital expenditures out of cash flows from operating activities. Capital...

BP 2Q Results 2006: Financial highlights 2Q and 1H 2006.
November 30, 2006... (From Chemical Business NewsBase - Company Reports - CBNB) For its 2Q 2006, BP plc has reported profit for the period of $7266 M ($5591 M for its 2Q 2005), replacement cost profit of $6118 ($4981 M), and EPS of $0.3028 ($0.2342). For its...

BP 2Q Results 2006: Gas, power, and renewables.
November 30, 2006... (From Chemical Business NewsBase - Company Reports - CBNB) For its 2Q 2006, the Gas, Power, and Renewables segment of BP plc has reported profit before interest and tax of $463 M ($175 M for its 2Q 2005) and replacement cost profit of...

Schering 2005: Segment reporting. [1 table in original article].
November 30, 2006... (From Chemical Business NewsBase - Company Reports - CBNB) For its fiscal 2005, Schering AG has reported net sales of EUR 5308 M (EUR 4907 M for its fiscal 2004), R&D expenditure of EUR 982 M (EUR 918 M), operating profit of EUR 928 M...

BP 2Q Results 2006: Summarised group income statement.
November 30, 2006... (From Chemical Business NewsBase - Company Reports - CBNB) For its 2Q 2006, BP plc has reported total revenues of $73,466 M ($59,268 M for its 2Q 2005), profit before interest and taxation from continuing operations of $10,813 M ($8010...

BP 2Q Results 2006: Exploration and production.
November 30, 2006... (From Chemical Business NewsBase - Company Reports - CBNB) For its 2Q 2006, the Exploration and Production segment of BP plc has reported profit before interest and tax of $7827 M ($5904 M for its 2Q 2005) and replacement cost profit of...

BP 2Q Results 2006: Analysis of profit before interest and tax. [1 table in original article].
November 30, 2006... (From Chemical Business NewsBase - Company Reports - CBNB) For its 2Q 2006 BP plc has profit before tax from continuing operations of $10,813 M ($8010 M for its 2Q 2005) and for its 1H 2006 profit before tax from continuing operations was...

BP 2Q Results 2006: Refining and marketing.
November 30, 2006... (From Chemical Business NewsBase - Company Reports - CBNB) For its 2Q 2006, the Refining and Marketing segment of BP plc has reported profit before interest and tax of $2992 M ($1932 M for its 2Q 2005) and replacement cost profit of...

Total in 2005: Key figures selected financial information.
November 30, 2006... (From Chemical Business NewsBase - Company Reports - CBNB) For its fiscal 2005 Total Sa has reported sales of EUR 143,168 M (EUR 121,998 M for its fiscal 2004), operating income of EUR 23,669 M (EUR 17,217 M), net income of EUR 12,003 M...

Total in 2005: Downstream.
November 30, 2006... (From Chemical Business NewsBase - Company Reports - CBNB) For its fiscal 2005 the Downstream segment of Total SA has reported non-group sales of EUR 99,934 M (EUR 86,896 M for its fiscal 2004), net income of EUR 2916 M (EUR 2331 M),...

BP 2Q Results 2006: Capital expenditure and acquisitions. [1 table in original article].
November 30, 2006... (From Chemical Business NewsBase - Company Reports - CBNB) For its 2Q 2006 BP plc has reported total capital expenditure of $3712 M ($3274 M for its 2Q 2005) and for its 1H 2006 capital expenditure was $6970 M ($6102 M for its 1H 2005). A...

Total in 2005: Chemicals - Base chemicals.
November 30, 2006... (From Chemical Business NewsBase - Company Reports - CBNB) For its fiscal 2005 the Chemicals segment of Total SA has reported on its Base Chemicals subsegment. Sales reached EUR 10.25 bn in 2005 (EUR 8.86 bn in 2004). Raw materials prices...

Total in 2005: Chemicals - Specialities.
November 30, 2006... (From Chemical Business NewsBase - Company Reports - CBNB) For its fiscal 2005 the Chemicals segment of Total SA has reported on its Specialities subsegment. Totals Specialties sector includes rubber processing (Hutchinson), resins (Cray...

Total in 2005: Arkema.
November 30, 2006... (From Chemical Business NewsBase - Company Reports - CBNB) For its fiscal 2005 the Chemicals segment of Total SA has reported on its Arkema subsegment. In 2004, Total reorganized its Chemicals segment by placing its chlorochemicals,...

Total in 2005: Five-year consolidated financial information. [1 table in original article].
November 30, 2006... (From Chemical Business NewsBase - Company Reports - CBNB) For its fiscal 2005 Total Sa has reported sales of EUR 143,168 M (EUR 121,998 M for its fiscal 2004), operating income of EUR 23,669 M (EUR 17,217 M), net income of EUR 12,003 M...

Total in 2005: Upstream.
November 30, 2006... (From Chemical Business NewsBase - Company Reports - CBNB) For its fiscal 2005 the Upstream segment of Total SA has reported non-group sales of EUR 20,888 M (EUR 15,037 M for its fiscal 2004), operating income of EUR 18,421 M (EUR 12,844...

BP 2Q Results 2006: Analysis of replacement cost profit before interest and tax. [1 table in original article].
November 30, 2006... (From Chemical Business NewsBase - Company Reports - CBNB) BP 2Q Results 2006: Analysis of profit before interest and tax. [1 table in original article] For its 2Q 2006 BP plc has reported replacement cost profit before interest and tax...

Total in 2005: Chemicals.
November 30, 2006... (From Chemical Business NewsBase - Company Reports - CBNB) For its fiscal 2005 the Chemicals segment of Total SA has reported non-group sales of EUR 22,326 M (EUR 20,042 M for its fiscal 2004), operating income of EUR 1349 M (EUR 1138...

Creon's first titanium dioxide conference sheds light on the Russian market.
November 30, 2006... (From Chemical Business NewsBase - Focus on Pigments) On 8 Sept 2006, Creon hosted its first international conference on titanium dioxide at Hotel Kempinski in Moscow. Mr Ruslan Yusupov (of DuPont) presented the opening paper. He pointed...

Cancer drugs harmful to brain cells.
November 30, 2006... (From Chemical Business NewsBase - The Independent) Common cancer drugs may be more harmful to the brain than the tumour cells they are meant to destroy. Laboratory tests have shown that dose levels typically used when treating patients...

Hambro Mining shares rocked by Russian attack.
November 30, 2006... (From Chemical Business NewsBase - The Independent) Shares in the AIM-listed Peter Hambro Mining plunged 14% on 29 Nov 2006 after a senior Russian government official questioned the legality and efficiency of the company's activities in...

Market report: pharmaceutical companies doing well.
November 30, 2006... (From Chemical Business NewsBase - The Independent) On 30 Nov 2006 the FTSE 100 ended a six-session losing streak by rallying 58 points to close at 6084. Pharmaceutical companies did particularly well after news that US giant Pfizer...

Michael Harrison's outlook: carbon trading comes of age.
November 30, 2006... (From Chemical Business NewsBase - The Independent) All markets take time to find their natural equilibrium and so it has proved with the one devised by Brussels to enable Europe to trade carbon permits. The first round of allocations two...

Rockwood announces agreement to sell Groupe Novasep to consortium led by Gilde Buyout Partners.
November 30, 2006... (From Chemical Business NewsBase - Press Release) Rockwood Holdings Inc (Rockwood) has signed a definitive agreement to sell its Groupe Novasep subsidiary to a consortium of buyers comprising Gilde Buyout Partners BV, Banexi Capital and...

Sonoco to acquire Clear Pack Co to expand rigid plastic container operations.
November 30, 2006... (From Chemical Business NewsBase - Press Release) Sonoco has signed an agreement to acquire Clear Pack Co, a privately held vertically integrated manufacturer of thermoformed and extruded plastic materials and containers, based in...

Albemarle raises price of FCC catalysts.
November 30, 2006... (From Chemical Business NewsBase - Press Release) Albemarle Corp will increase globally the price of its fluidized catalytic cracking (FCC) catalysts to a minimum of $2700/tonne effective 1 Jan 2007, or as contracts allow. Albemarle is a...

InterfaceFABRIC creates next generation upholstery fabric for 2008 Ford Escape Hybrid.
November 30, 2006... (From Chemical Business NewsBase - Press Release) Made from soda bottle resin, the 100% post-industrial recycled polyester fabric featured in the 2008 Ford Escape Hybrid is the result of a collaboration between teams at Ford and...

Congressman McNulty unveils MTI's fuel cell system.
November 30, 2006... (From Chemical Business NewsBase - Press Release) MTI MicroFuel Cells (MTI Micro) is now ready to accept orders for its Mobion 30M systems from qualified customers as the company moves to set-up military market test sites. At a meeting...

Alltracel announces successful development of a highly soluble derivative of its patented cardiovascular health benefiting bioactive.
November 30, 2006... (From Chemical Business NewsBase - Press Release) Alltracel Pharmaceuticals Plc (Alltracel) confirmed the successful development of a highly soluble derivative of its patented cardiovascular health benefiting bioactive. This successful...

Positive Phase I results reported for Durect's second abuse-resistant opioid pain medicine.
November 30, 2006... (From Chemical Business NewsBase - Press Release) Durect Corp reported positive results from a Phase I clinical trial evaluating an abuse-resistant opioid pain drug candidate based on Durect's patented Oradur technology. The event was...

Anesiva and Lumen Therapeutics enter agreement granting Lumen access to data from studies in bypass procedures.
November 30, 2006... (From Chemical Business NewsBase - Press Release) Anesiva Inc and Lumen Therapeutics (Lumen) have entered into an agreement, which grants Lumen a non-exclusive licence to clinical data and technical information relating to the prevention...

Osteotech licences patents to Bacterin.
November 30, 2006... (From Chemical Business NewsBase - Press Release) Osteotech Inc has entered into a licence agreement with Bacterin International Inc (Bacterin), a biologics company and manufacturer of elutive bioactive coatings for medical devices. Under...

Newly presented data on VESIcare (solifenacin succinate) show significant improvements in urgency for patients with overactive bladder.
November 30, 2006... (From Chemical Business NewsBase - Press Release) Patients with overactive bladder (OAB) treated with VESIcare (solifenacin succinate) experienced statistically significant reductions in episodes of urgency, according to a new study...

Lentigen Corp receives grant from the NIH to develop a potential new therapy for the treatment of Chronic Lymphocytic Leukaemia.
November 30, 2006... (From Chemical Business NewsBase - Press Release) Lentigen Corp has received National Institute of Health (NIH) Small Business Innovation Research (SBIR) funding to develop an improved and novel therapy for patients with Chronic...

FDA approved Anthelios SX daily moisturizing cream with sunscreen with Mexoryl SX by La Roche-Posay is now available for consumer purchase.
November 30, 2006... (From Chemical Business NewsBase - Press Release) La Roche-Posay announces that consumers in the US can now purchase Anthelios SX with Mexoryl SX (ecamsule). Anthelios SX SPF 15 is a new, revolutionary daily moisturizing cream with...

Carrington and Mannatech extend supply and trademark agreement for Manapol powder.
November 30, 2006... (From Chemical Business NewsBase - Press Release) Carrington Laboratories Inc (Carrington) has signed a letter of intent with Mannatech Inc to provide for a supply and trademark agreement for Manapol powder. Under the agreed upon...

Biocrates and Pfizer global R&D report on joint metabolomics study.
November 30, 2006... (From Chemical Business NewsBase - Press Release) Biocrates Life Sciences GmbH (Biocrates) and Pfizer Inc successfully completed a pre-clinical pilot study to reveal candidate biomarkers for early events in vascular injury. Results will...

Inco and Sud-Chemie establish joint venture for development of diesel emission control materials and catalysts.
November 30, 2006... (From Chemical Business NewsBase - Press Release) Inco Ltd and Sud-Chemie AG, Munich, Germany have agreed to establish a joint venture company for the production and marketing of catalyzed diesel emission control materials for the...

Global Alumina announces extension of time period with respect to joint venture negotiations.
November 30, 2006... (From Chemical Business NewsBase - Press Release) Global Alumina Corp and the lenders under the previously announced $100 M Loan Facility Agreement have agreed to extend from 30 Nov 2006 to 31 Dec 2006 the deadline for the negotiation of...

VeraSun Energy begins construction on fifth ethanol biorefinery, near Welcome, MN.
November 30, 2006... (From Chemical Business NewsBase - Press Release) VeraSun Energy Corp (VeraSun) announced that it began construction on its fifth ethanol production facility. The new facility will be a 110-M-gallon/y plant located near Welcome, MN. The...

Global Resources enters final negotiations for the sale and development of the first pilot plant utilizing its newly acquired revolutionary microwave technology.
November 30, 2006... (From Chemical Business NewsBase - Press Release) Global Resources (GBRC) announced the sale of the first continuous feed shale oil cracking system. This system is being designed and is using GBRC's patent pending process. The system will...

Motiva enters final planning phase for proposed Port Arthur refinery expansion.
November 30, 2006... (From Chemical Business NewsBase - Press Release) Motiva Enterprises LLC (Motiva) announced plans to move forward with the final design and engineering phase for a proposed 325,000 bbls/day capacity expansion project at its Port Arthur,...

Indian Oil, Bongaigaon boards okay merger plan.
November 30, 2006... (From Chemical Business NewsBase - Business Line) The board of directors of Indian Oil Corp Ltd (Indian Oil) and Bongaigaon Refinery and Petrochemicals Ltd (Bongaigaon) have cleared the proposal to merge Bongaigaon with Indian Oil,...

Dr Reddys in pact with Torrent.
November 30, 2006... (From Chemical Business NewsBase - Business Line) Dr Reddys Laboratories (Dr Reddys) has entered into an agreement with Torrent Pharmaceuticals (Torrent) under which, Dr Reddys will have exclusive commercialisation rights in Russia for...

Kansai Nerolac to step up capacity.
November 30, 2006... (From Chemical Business NewsBase - Business Line) Paints manufacturer Kansai Nerolac Ltd proposes to invest Rup 1 bn to hike its paint manufacturing capacity by 20,000 tonnes/y. The company, which has a manufacturing capacity of 158.300...

Nandan Biomatrix launches plant extracts.
November 30, 2006... (From Chemical Business NewsBase - Business Line) The Hyderabad-based manufacturer of neutraceuticals Nandan Biomatrix Ltd has introduced standardised medicinal plant extracts in the aphrodisiac, cosmetic, nutritional supplements and...

Petrol, diesel prices cut: Relief to consumers, but margins of oil marketing companies may take hit. [1 table in original article].
November 30, 2006... (From Chemical Business NewsBase - Business Line) The Government of India has announced a reduction in prices of petrol by Rup 2/lt and on diesel by Rup 1/lt sold by State-owned oil marketing companies with effect from midnight of 29 Nov...

Vanaspati industry split over duty-free imports: 12 Indian firms having units in Lanka likely to gain.
November 30, 2006... (From Chemical Business NewsBase - Business Line) The decision of the Government of India to decanalise and allow 250,000 tonnes of duty-free imports of vanaspati from Lanka has been received with mixed reaction in the Rup 70 bn Indian...

Richter expands in Romania.
November 30, 2006... (From Chemical Business NewsBase - Nachrichten fuer Aussenhandel) Via its Romanian subsidiary Armedica, Hungarian drug company Richter is acquiring a 94% stake in drugs chain Bioplus Pharm. Media reports say Richter is paying EUR 600,000.